Blue Cross Blue Shield of Minnesota, et. al. v. Pfizer, Inc., Warner-Lambert Company LLC, et. al.

Representation of Blue Cross of Massachusetts and other health insurers in drug overpayment litigation arising from Pfizer’s off-label marketing of Neurontin. 
Past results are reported to provide the reader with an indication of the type of litigation we practice. They do not and should not be construed to create an expectation of result in any other case, as all cases are dependent upon their own unique fact situation and applicable law.
Disclaimer
Back to Top